Article Information
History
- March 31, 2021.
Article Versions
- Version 1 (June 5, 2020 - 10:43).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Zhaoyi Chen1,
- Hansi Zhang1,
- Yi Guo1,
- Thomas J George2,
- Mattia Prosperi3,
- William R Hogan1,
- Zhe He4,
- Elizabeth A Shenkman1,
- Fei Wang5 and
- Jiang Bian1,*
- 1Health Outcomes & Biomedical Informatics, University of Florida, Gainesville, Florida, USA
- 2Hematology & Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA
- 3Department of Epidemiology, College of Public Health and Health Professions & College of Medicine, University of Florida, Gainesville, Florida, USA
- 4School of Information, Florida State University, Tallahassee, Florida, USA
- 5Department of Healthcare Policy and Research, Cornell University, New York, USA
- ↵*Corresponding author: Jiang Bian, PhD, College of Medicine, University of Florida, 2197 Mowry Road Suite 122, PO Box 100177, Gainesville, FL 32610-0177, bianjiang{at}ufl.edu, 352 273-8878
Posted March 31, 2021.
Exploring the Feasibility of Using Real-World Data from a Large Clinical Data Research Network to Simulate Clinical Trials of Alzheimer’s Disease
